Prof. Yukio Nagasaki

Visiting Research Fellow, Center for Applied Nanomedicine, National Cheng Kung University, Taiwan
Professor Emeritus, Department of Materials Science, Faculty of pure and Applied Science, University of Tsukuba, Japan

Yukio Nagasaki was born in 1959. After graduating from the Science University of Tokyo in 1987, he began his academic career there, serving successively as a Research Associate, Assistant Professor, Associate Professor, and Professor. In 2004, he moved to the Faculty of Pure and Applied Sciences at the University of Tsukuba, where he continued his research and teaching activities. Upon his retirement as a full professor, he was granted the title of Professor Emeritus at the University of Tsukuba. In April 2025, he was appointed as a Yushan Fellow and began working at National Cheng Kung University in Taiwan.
Professor Nagasaki has been actively engaged in the field of materials science throughout his career, with particular emphasis on its applications in biology, pharmaceuticals, and medical science. His research has focused on biointerfaces, drug delivery systems (DDS), and anomedicine. He has authored more than 300 peer-reviewed scientific publications.

Prof. Hai-Quan Mao

Director, Institute of NanoBioTechnology, Johns Hopkins University
Professor, Department of Materials Science and Engineering, Whiting School of Engineering,  Johns Hopkins University, USA
Professor, Department of Biomedical Engineering, Translational Tissue Engineering Center, School of Medicine,  Johns Hopkins University, USA

Dr. Hai-Quan Mao is the Director of the Institute of NanoBioTechnology (INBT) and Professor of Materials Science and Engineering at the Whiting School of Engineering, Johns Hopkins University. He holds a joint appointment in the Department of Biomedical Engineering and is a core faculty member of the Translational Tissue Engineering Center at the School of Medicine.
Dr. Mao received his B.S. degree in Chemistry and a Ph.D. in Polymer Chemistry from Wuhan University in China in 1988 and 1993, respectively. From 1995 to 1998, he pursued his postdoctoral training in the Department of Biomedical Engineering at Johns Hopkins University School of Medicine. He was a co-principal investigator at Johns Hopkins in Singapore from 1999 to 2003 before joining the faculty of the Whiting School of Engineering at Johns Hopkins University.

Dr. Mao’s research integrates materials science, immuno-engineering, and nanotechnology to design nanofiber-hydrogel composites for soft-tissue repair and stem cell delivery, develop machine learning-guided cell-specific lipid nanoparticle design and scalable manufacturing platforms for nucleic-acid and protein nanotherapeutics, and engineer biomimetic matrices that program immune responses. Dr. Mao is an associate editor of Biomaterials and serves on the editorial boards of ACS Biomaterials Science & Engineering and Journal of Materials Chemistry B. Dr. Mao is a recipient of the National Science Foundation Faculty CAREER Award and a fellow of the National Academy of Inventors and the American Institute for Medical and Biological Engineering.

Prof. Yoshiki Katayama

President, National Institute of Technology, Kitakyushu College, Japan
Professor Emeritus, Department of Applied Chemistry, Kyushu University, Japan
Professor (international joint appointment) , Department of Biomedical Engineering, Chung Yuan Christian University, Taiwan

Prof Yoshiki Katayama received B.Sc. from Kagoshima University in 1982, and Ph.D. from Kyushu University with Prof. Makoto Takagi in 1987. After working at Dojindo Molecular Technologies, Inc. for nine years as a director of R&D department, he became Assoc. Prof. of Kyushu University and was promoted to Professor in 2002. Since 2019, he has served as the Dean of School of Systems Life Science of Kyushu University. After retirement, he was appointed President of the National Institute of Technology, Kitakyushu College.
He focuses on the molecular mechanisms of aging, longevity genes, and the development of anti-aging foods, and also works on interdisciplinary research, includes gene design, biological and chemical methods, drug development, and gene delivery technologies. He has held leadership roles in the Japanese Chemical Society and the Society for Biological Chemistry, and actively participates in international research collaborations and industry-academia partnerships.

Prof. Kun Hu

Prof. Li-Jiuan Shen

Professor and Associate Dean for International Affairs, College of Medicine, National Taiwan University, Taiwan (R.O.C.)
Pharmacist, Department of Pharmacy, National Taiwan University Hospital, Taiwan
Chairman, Ching-Kang Foundation for Pharmacy Promotion

Prof. Li-Jiuan Shen is the Vice Dean of the College of Medicine and a Professor in the Department of Pharmacy at National Taiwan University. She also serves as the Chairman of the Ching-Kang Foundation for Pharmacy Promotion. Her research interests encompass clinical pharmacy, pharmacotherapy management, and drug safety assessment.

Prof. Shen has published numerous papers in both domestic and international academic journals and has contributed to the authorship of several professional books. She is an active participant in academic conferences worldwide, frequently serving as an invited speaker to share her research findings and expertise.

Her work focuses on developing innovative pharmacy service models that integrate pharmaceutical expertise with clinical applications, aiming to enhance economic efficiency and optimize resource allocation. Additionally, she explores novel management mechanisms aligned with the evolution of Taiwan’s National Health Insurance system.

Prof. Ching-Li Tseng

Professor, Graduate Institute of Biomedical Materials and Tissue Engineering, Taipei Medical University, Taiwan (R.O.C.)
Visiting Researcher, Centre for Eye Research Australia

The research focus of Prof. Tseng is biomaterials application in drug delivery and tissue repair. Especially in non-invasive way to deliver nanomedicine for disease treatment, for example inhalation of nanomedicine for treating lung cancer/fibrosis, and nanoparticles contained eye-drops for .ophthalmic disease treatment. She continuously works on the specific drug/gene delivery system in ophthalmology to find an effectively and friendly way to treat eye disease for clinic application such as dry eye syndrome, corneal/choroidal neovascularization, and blue light damage treatment.

Prof. Hsin Chen